Merck & Co has announced FDA approval for Keytruda (pembrolizumab) combined with chemotherapy for first-line treatment of ...

MAIA Biotechnology announced positive interim survival data for its lead candidate, THIO, in a Phase II trial for advanced ...

Canada’s NanoVation Therapeutics, a privately-held platform company developing innovative technologies to overcome the ...

Women’s health specialist Organon has entered into a definitive agreement to acquire Dermavant Sciences, a Roivant company.

The US Food and Drug Administration (FDA) has approved Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) ...

Novo Nordisk is under pressure over US drug prices as CEO Lars Fruergaard Jørgensen prepares to testify before the Senate ...

Coherus Biosciences has seen a 24% drop in share price due to supply chain issues affecting Udenyca (pegfilgrastim-cbqv), a ...

Athira Pharma is refocusing efforts on ATH-1105 after its Alzheimer’s drug, fosgonimeton, failed to meet endpoints in the ...

Gene therapy research in Japan has gained significant momentum due to the SAKIGAKE designation system and government-led ...

Los Angeles-based City of Hope has received a $150 million donation from investor Emmet Stephenson and his daughter, Tessa, ...

In a lawsuit filed in federal court in Missouri, USA, Health insurer Cigna (NYSE: CI) and its pharmacy benefit manager (PBM) ...

Yesterday, the US Food and Drug Administration (FDA) issued a draft guidance, “Integrating Randomized Controlled Trials for ...